Everything below concerns Angiotensin IV. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-17. Numbers and descriptions here follow the published literature rather than marketing material.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
| Property | Value | Notes |
|---|---|---|
| Molecular target | HGF/c-Met pathway | Proposed, not fully confirmed |
| Research models | Rodent cognition assays | Results vary by study |
| Human trial data | Limited or absent | No approved clinical use |
| Metabolic stability | Uncertain | Peptide degradation possible |
| Blood-brain barrier | Under investigation | Lipophilicity may affect distribution |
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
===== Guyana ===== In February 2024, president Lula announced he would visit Guyana and meet president Irfaan Ali to discuss topics such as the Essequiba border dispute with Venezuela and a potential hydro-power energy sharing agreement between Guyana and Brazil. On 28 February, Lula spoke at a CARICOM summit in Georgetown in which he said he intends Brazil to resume having diplomatic missions in the Caribbean nations. Lula added Brazil was making a monetary contribution to the Caribbean Development Bank.
=== List of resources === PhosphoSitePlus – A database of comprehensive information and tools for the study of mammalian protein post-translational modification ProteomeScout – A database of proteins and post-translational modifications experimentally Human Protein Reference Database – A database for different modifications and understand different proteins, their class, and function/process related to disease causing proteins PROSITE – A database of Consensus patterns for many types of PTM's including sites RESID – A database consisting of a collection of annotations and structures for PTMs. iPTMnet– A database that integrates PTM information from several knowledgbases and text mining results. dbPTM – A database that shows different PTM's and information regarding their chemical components/structures and a frequency for amino acid modified site Uniprot has PTM information although that may be less comprehensive than in more specialized databases. The O-GlcNAc Database - A curated database for protein O-GlcNAcylation and referencing more than 14 000 protein entries and 10 000 O-GlcNAc sites.
In 1611 Johannes Kepler studied the packing of spheres, in order to explain the hexagonal symmetry of snow crystals. Kepler demonstrated that in a compact packing each sphere has six neighbours in the same plane, three in the plane above, and three in the plane below, for a total of twelve touching spheres. Kepler concluded that π/(3√2) = 0.74084 is the maximum possible density amongst any arrangement of spheres — this became known as the Kepler conjecture. The conjecture was finally proved by Thomas Hales in 1998. By the second half of the 17th century the ideas of Paracelsus had been displaced by a more scientific approach to chemistry, geology, mineralogy, and the emerging field of crystallography. In his book The Sceptical Chymist of 1661, Robert Boyle criticized the traditional composition of materials, as represented by the teaching of Aristotle and Paracelsus, and initiated the modern understanding of chemical elements using the words "perfectly unmingled bodies". Boyle argued that matter's basic elements consisted of various types of particles, termed "corpuscles", which were capable of arranging themselves into groups (molecules). Boyle was one of the earliest researchers to use the term crystal for crystalline substances apart from quartz. In 1665 Robert Hooke attempted to explain crystal morphology based on the stacking of atoms. In his work Micrographia he reported on the regularity of quartz crystals observed with the recently invented microscope, and proposed that they are formed by spherules.
Sources: en.wikipedia.org
=== Initial appearance === The first known documented instance of an attack by the Phylloxera in France was in the village of Pujaut in the department of Gard of the former province of Languedoc, in 1863. The wine makers there did not notice the aphids, just as the French colonists in America had not, but they noted the mysterious blight that was damaging their vines. The only description of the disease that was given by these wine growers was that it "reminded them distressingly of 'consumption'"(tuberculosis). The blight quickly spread throughout France, but it was several years before the cause of the disease was determined.
The Ministry of Justice confirms that serial killer Levi Bellfield, who is serving two whole life sentences for murder, will be allowed to marry his girlfriend in prison as there are no legal restrictions preventing him from doing so. Boris Johnson breaks the Ministerial Code for a second time, by not asking advice from the Advisory Committee on Business Appointments before accepting a new job writing for the Daily Mail. The previous time was shortly after he stood down as foreign secretary in July 2018, when he accepted a similar job with the Daily Telegraph. A 31-year-old man is charged with three counts of murder and three of attempted murder following the Nottingham attacks. 17 June David Warburton, the MP for Somerton and Frome, becomes the fourth Conservative MP in eight days to announce their resignation from the House of Commons, doing so following his suspension from the party over allegations of sexual misconduct, and triggering a by-election in his constituency. The 2023 Trooping the Colour ceremony takes place. 18 June – Partygate: The Mirror publishes video footage of a party held in December 2020 at Conservative Party Headquarters. Housing Secretary Michael Gove describes the incident as "indefensible". 19 June – Partygate: MPs back, by 354 votes to seven, a report finding Boris Johnson deliberately misled the Commons over lockdown parties at Downing Street. 20 June The Chancellor, Jeremy Hunt, rules out direct financial support for mortgage holders, over fears it would "make inflation worse, not better".
Hummingbirds resemble sunbirds. The former live in the Americas and belong to an order or superorder including the swifts, while the latter live in Africa and Asia and are a family in the order Passeriformes. Also the nectar-feeding Hawaiian honeycreepers resemble the two and differs from other honeycreeper. Flightlessness has evolved in many different birds independently. However, taking this to a greater extreme, the terror birds, Gastornithiformes and dromornithids (ironically all extinct) all evolved the similar body shape (flightlessness, long legs, long necks, big heads), yet none of them were closely related. They also share the trait of being giant, flightless birds with vestigial wings, long legs, and long necks with the ratites, although they are not related. Certain longclaws (Macronyx) and meadowlarks (Sturnella) have essentially the same striking plumage pattern. The former inhabit Africa and the latter the Americas, and they belong to different lineages of Passerida. While they are ecologically quite similar, no satisfying explanation exists for the convergent plumage; it is best explained by sheer chance. Resemblances between swifts and swallows is due to convergent evolution. The chimney swift was originally identified as chimney swallow (Hirundo pelagica) by Carl Linnaeus in 1758, before being moved to the swift genus Chaetura by James Francis Stephens in 1825.
Sources: en.wikipedia.org
It is thought to enhance hepatocyte growth factor signaling through the c-Met receptor. This pathway is involved in cell growth and repair. The precise molecular details are not fully established.
Published human trials are lacking. Most data come from cell cultures and animal models. Therefore, clinical effects and safety in people are uncertain.
It has been promoted in online communities for cognitive enhancement. That discussion is based largely on preclinical findings. It does not constitute evidence of efficacy or safety.
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.